Evidence map›Paper›PMID 30482200›Full record

ArticleBMC pulmonary medicine2018

Role of TLR4-p38 MAPK-Hsp27 signal pathway in LPS-induced pulmonary epithelial hyperpermeability.

Weiju Wang, Jie Weng, Lei Yu, Qiaobing Huang, Yong Jiang, Xiaohua Guo

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Arteriosclerosis, thrombosis, and vascular biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular medicine reports · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Weiju WangDepartment of Pathophysiology, Guangdong Province Key Laboratory for Shock and Microcirculation Research, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, 510515, China.
Jie WengDepartment of Pathophysiology, Guangdong Province Key Laboratory for Shock and Microcirculation Research, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, 510515, China.
Lei YuDepartment of Pathophysiology, Guangdong Province Key Laboratory for Shock and Microcirculation Research, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, 510515, China.
Qiaobing HuangDepartment of Pathophysiology, Guangdong Province Key Laboratory for Shock and Microcirculation Research, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, 510515, China. bing@smu.edu.cn.
Yong JiangDepartment of Pathophysiology, Guangdong Province Key Laboratory for Shock and Microcirculation Research, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, 510515, China. jiang48231@163.com.
Xiaohua GuoDepartment of Pathophysiology, Guangdong Province Key Laboratory for Shock and Microcirculation Research, Guangdong Provincial Key Laboratory of Proteomics, State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, 510515, China. lanblue@smu.edu.cn.ORCID http://orcid.org/0000-0001-8888-4493
Southern Medical University · CNKey Laboratory of Guangdong Province · CN

Funding

Guangdong Natural Science Foundation 2014A030313301National Natural Science Foundation of China 81670076National Natural Science Foundation of China (CN) 81372030
6 · The paper itself

Abstract

backgroundThe breakdown of alveolar barrier dysfunction contributes to Lipopolysaccharide stimulated pulmonary edema and acute lung injury. Actin cytoskeleton has been implicated to be critical in regulation of epithelial barrier. Here, we performed in vivo and in vitro study to investigate role of TLR4-p38 MAPK-Hsp27 signal pathway in LPS-induced ALI.

methodsFor in vivo studies, 6-8-week-old C57 mice were used, Bronchoalveolar lavage Fluid /Blood fluorescent ratio, wet-to-dry lung weight ratio, as well as protein concentrations and neutrophil cell counts in BALF were detected as either directly or indirectly indicators of pulmonary alveolar barrier dysfunction. And hematoxylin and eosin staining was performed to estimate pulmonary injury. The in vitro explorations of transepithelial permeability were achieved through transepithelial electrical resistance measurement and testing of FITC-Dextran transepithelial flux in A549. In addition, cytoskeletal rearrangement was tested through F-actin immunostaining. And SB203580 was used to inhibit p38 MAPK activation, while siRNA was administered to genetically knockdown specific protein.

resultsWe showed that LPS triggered activation of p38 MAPK, rearrangement of cytoskeleton which resulted in severe epithelial hyperpermeability and lung edema. A549 pretreated with TLR4 siRNA、p38 MAPK siRNA and its inhibitor SB203580 displayed a lower permeability and fewer stress fibers formation after LPS stimulation, accompanied with lower phosphorylation level of p38 MAPK and Hsp27, which verified the involvement of TLR4-p38 MAPK-Hsp27 in LPS-evoked alveolar epithelial injury. Inhibition of p38 MAPK activity with SB203580 in vivo attenuated pulmonary edema formation and hyperpermeability in response to LPS.

conclusionsOur study demonstrated that LPS increased alveolar epithelial permeability both in vitro and in vivo and that TLR4- p38 MAPK- Hsp27 signal pathway dependent actin remolding was involved in this process.

Indexed as

Signal TransductionA549 CellsAcute Lung InjuryAnimalsBronchoalveolar Lavage FluidCells, CulturedHSP27 Heat-Shock ProteinsHumansImidazolesLipopolysaccharidesLungMaleMicep38 Mitogen-Activated Protein KinasesPermeabilityPhosphorylationHSP27 Heat-Shock ProteinsImidazolesLipopolysaccharidesp38 Mitogen-Activated Protein KinasesPyridinesSB 203580Toll-Like Receptor 4ALIAlveolar barrier dysfunctionCytoskeletal rearrangementHsp27LPSP38 MAPKTLR4

Identifiers

PMID30482200
PMCPMC6258407
OpenAlexW2902470477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.